Home
Scholarly Works
Fondaparinux reduces symptomatic pulmonary...
Conference

Fondaparinux reduces symptomatic pulmonary embolism and death in patients hospitalized with congestive heart failure: a sub-analysis of the randomized ARTEMIS trial

Authors

Eikelboom J; Cohen AT; Turpie AGG

Volume

28

Pagination

pp. 50-50

Publisher

OXFORD UNIV PRESS

Publication Date

September 1, 2007

Conference proceedings

EUROPEAN HEART JOURNAL

ISSN

0195-668X

Contact the Experts team